Market research
THYROCARE.NSE Thyrocare Technologies Limited
NSE INR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 93B
- P/E ratio
- 52.95
- Analyst target
- 663
- Dividend yield
- 0.0%
- Beta
- 0.46
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- INE594H01019
- Market cap
- 93B
- P/E ratio
- 52.95
- Analyst target
- 663
- Dividend yield
- 0.0%
- Beta
- 0.46
About
About Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the THYROCARE.NSE discussion.
5 years, 5 months ago
Thyrocare Technologies Limited is currently in a long term uptrend where the price is trading 30.7% above its 200 day moving average.
From a valuation standpoint, the stock is 150.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.0.
Thyrocare Technologies Limited's total revenue rose by 30.7% to $1B since the same quarter in the previous year.
Its net income has increased by 17.8% to $324M since the same quarter in the previous year.
Finally, its free cash flow fell by 75.3% to $221M since the same quarter in the previous year.
Based on the above factors, Thyrocare Technologies Limited gets an overall score of 3/5.